What does Egeiro Pharma do?
TheraVet is a biotechnology company specializing in the development of innovative therapies for the treatment of bone and joint diseases in pets. The company focuses on regenerative medicine and provides solutions that enhance the healing process in veterinary medicine. TheraVet aims to improve the quality of life for animals through advanced therapeutic options.
- Sectors
- Forestry companies
- Signals
-
Juridical warningJuridical warning
The legal status points to elevated risk (e.g. dissolution or bankruptcy).
Reporting lossesReporting losses € -2.18MThe company reported a loss in the latest financial year.
Negative cashflowNegative cashflow € -507KOperating cash flow was negative in the latest financial year.
Negative EBITDANegative EBITDA € -1.11MEBITDA is negative: operating activities are loss-making.
Strong equityStrong equity € 6.05MStrong equity provides a buffer against setbacks.
Low riskLow risk 80.3%Good solvency (> 30%) points to long-term financial stability.
Good liquidityGood liquidity 3.40A healthy current ratio (≥ 1.5): enough current assets to cover short-term debt.
Healthy social debtHealthy social debt 13.0%Social debts stay manageable relative to personnel costs.
Financial ratios
|
|
2023
|
2022
|
2021
|
2020
|
|---|---|---|---|---|
|
€
118K
|
€
94K
|
€
12K
|
|
|
|
€
-1.11M
|
€
-1.68M
|
€
-1.17M
|
€
-355K
|
|
|
€
-1.57M
|
€
-2.32M
|
€
-1.34M
|
€
-388K
|
|
|
€
6.05M
|
€
7.52M
|
€
9.65M
|
€
3.39M
|
|
|
80.29%
|
79.15%
|
84.25%
|
66.37%
|
|
|
€
1.48M
|
€
1.98M
|
€
1.80M
|
€
1.72M
|
|
|
€
1.15M
|
€
3.19M
|
€
5.63M
|
€
2.17M
|
|
|
6.60
|
11.00
|
13.00
|
4.90
|
Publications 17
All publications- Divers 05/12/2023
- Demissions, Nominations 23/11/2023
- Demissions, Nominations 20/06/2023
- Demissions, Nominations 05/01/2023
- Demissions, Nominations 10/11/2022
Frequently asked questions
Answers to the most common questions about Egeiro Pharma, based on official government data and the filed annual accounts.
What is the VAT number of Egeiro Pharma?
The VAT number of Egeiro Pharma is BE0684.906.013.
How many employees work at Egeiro Pharma?
In 2023, Egeiro Pharma employed 6.60 full-time equivalents (FTE).
When was Egeiro Pharma established?
Egeiro Pharma was founded in 22-11-2017.
What is the official address of Egeiro Pharma?
The official address of Egeiro Pharma is Avenue Jean Mermoz 32/1 Charleroi 6041 Bâtiment Biotech 3.
What is the legal form of Egeiro Pharma?
The juridical form of Egeiro Pharma is Public limited company (NV/SA).
What is the annual revenue of Egeiro Pharma?
The revenue of Egeiro Pharma for the 2023 financial year was €117,839.
What does Egeiro Pharma do?
TheraVet is a biotechnology company specializing in the development of innovative therapies for the treatment of bone and joint diseases in pets. The company focuses on regenerative medicine and provides solutions that enhance the healing process in veterinary medicine. TheraVet aims to improve the quality of life for animals through advanced therapeutic options.
Is Egeiro Pharma a reliable company?
Egeiro Pharma is a registered Rechtspersoon with company number 0684.906.013 and can be verified through the official CBE database.
What is the credit limit of Egeiro Pharma?
The estimated credit limit of Egeiro Pharma is €255,004.
Is Egeiro Pharma still active?
Egeiro Pharma currently has the status "Opening faillissement" and is not active.